19 filings
8-K
ROSS
Ross Acquisition Corp II - Ordinary Shares
18 Mar 24
Ross Acquisition Corp II Announces Suspension and Expected De-Listing from the New York Stock
6:30am
8-K
ROSS
Ross Acquisition Corp II - Ordinary Shares
15 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
ROSS
Ross Acquisition Corp II - Ordinary Shares
6 Mar 24
Submission of Matters to a Vote of Security Holders
6:53pm
8-K
ROSS
Ross Acquisition Corp II - Ordinary Shares
29 Feb 24
Ross Acquisition Corp II Announces Meeting for Shareholders
4:25pm
8-K
ROSS
Ross Acquisition Corp II - Ordinary Shares
10 Oct 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:58pm
8-K
45yoh7w
15 Sep 23
Ross Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business Combination
2:49pm
8-K
yvvg3gmr
1 Sep 23
Ross Acquisition Corp II Announces Meeting for Shareholders
6:15am
8-K
at0hr13
28 Aug 23
Ross Acquisition Corp IiĀ Receives Nyse Notice Regarding Delayed Form 10-Q Filing
4:37pm
8-K
ckynm8bazmtb
21 Aug 23
Termination of a Material Definitive Agreement
4:16pm
8-K
h8md5 knc9nnu7
18 Aug 23
Regulation FD Disclosure
9:18am
8-K
np9hsq2
5 Apr 23
Entry into a Material Definitive Agreement
4:15pm
8-K
cqli6 8fm7qf7cb7sbg
13 Mar 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
2d6ywbo
18 Jan 23
ROSS SPAC will issue $280 million of stock for APRINOIA Therapeutics
6:55am
8-K/A
xkwbvry2ootfb
4 Jan 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
dgpvme
17 Dec 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:26pm
8-K
p8pjfhlxgvx bzfspl
28 May 21
Ross Acquisition Corp II Receives Expected NYSE Notice Regarding Delayed Form 10-Q Filing
12:00am
8-K
nmfnpv19y7row
3 May 21
Other Events
1:07pm
8-K
upgpmnjs8tdc7
23 Mar 21
Ross Acquisition Corp Ii
12:00am
8-K
pl4 45ekjws
16 Mar 21
Ross Acquisition Corp II Announces Pricing of $300 Million Initial Public Offering
5:28pm
- Prev
- 1
- Next